Nrf2 has been shown to be highly activated in studies in BCa, where upregulation of Nrf2 leads to poor prognosis in BCa patients, and that overexpression in BCa cells accelerates tumour cell progression 10, 11. Here, NFE2L2 is linked to neoplasm.